标题
The role of MET in chemotherapy resistance
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-02
DOI
10.1038/s41388-020-01577-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MET targeting: time for a rematch
- (2020) Jonas P. Koch et al. ONCOGENE
- Metabolic Plasticity in Chemotherapy Resistance
- (2020) Maria Andrea Desbats et al. Frontiers in Oncology
- Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
- (2020) Qiumo Zhang et al. International Journal of Nanomedicine
- Guidelines and definitions for research on epithelial–mesenchymal transition
- (2020) Jing Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
- (2020) Jiabei Zhou et al. Frontiers in Pharmacology
- Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma
- (2019) Takeo Hara et al. ANNALS OF SURGICAL ONCOLOGY
- Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion
- (2019) Veronica S. Hughes et al. Oncotarget
- Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
- (2019) Wei Lu et al. DEVELOPMENTAL CELL
- Targeting Cancer Stem Cells to Overcome Chemoresistance
- (2018) Toni Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome
- (2018) Lizhou Jia et al. MEDICAL SCIENCE MONITOR
- Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy
- (2017) Nicole Glodde et al. IMMUNITY
- Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway
- (2017) Xia-li Tang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Daniel V T Catenacci et al. LANCET ONCOLOGY
- Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment
- (2017) Agnieszka A. Rucki et al. MOLECULAR CANCER THERAPEUTICS
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
- (2017) Andrew N. Blackford et al. MOLECULAR CELL
- Modeling Physiological Events in 2D vs. 3D Cell Culture
- (2017) Kayla Duval et al. PHYSIOLOGY
- Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
- (2017) Srinivasa P. Pothula et al. Oncotarget
- MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
- (2017) Sean Caenepeel et al. Oncotarget
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- c-Met inhibition enhances chemosensitivity of human ovarian cancer cells
- (2016) Jing Wang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
- (2016) Menggui Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- (2016) Toni K Choueiri et al. LANCET ONCOLOGY
- High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form
- (2016) Marie-Christine Copin et al. LUNG CANCER
- Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis
- (2016) Si Sun et al. PLoS One
- miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET
- (2016) Qing-yong Chen et al. Oncotarget
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
- (2015) Franziska Brandes et al. BMC CANCER
- Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines
- (2015) T-H Hung et al. CANCER GENE THERAPY
- Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
- (2015) I. Watermann et al. Diagnostic Pathology
- High levels of c-Met is associated with poor prognosis in glioblastoma
- (2015) Stine Asferg Petterson et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- MET is required for the recruitment of anti-tumoural neutrophils
- (2015) Veronica Finisguerra et al. NATURE
- Small molecule inhibitor of c-Met (PHA665752) suppresses the growth of ovarian cancer cells and reverses cisplatin resistance
- (2015) Enze Li et al. TUMOR BIOLOGY
- c-Met Overexpression Contributes to the Acquired Apoptotic Resistance of Nonadherent Ovarian Cancer Cells through a Cross Talk Mediated by Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase 1/2
- (2015) Maggie K.S. Tang et al. NEOPLASIA
- Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cells
- (2014) Hiroaki Ozasa et al. CANCER SCIENCE
- Met endosomal signalling: In the right place, at the right time
- (2014) Rachel Barrow-McGee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- The role of P-glycoprotein in drug resistance in multiple myeloma
- (2014) Joseph Abraham et al. LEUKEMIA & LYMPHOMA
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
- (2014) Daniel Delitto WORLD JOURNAL OF GASTROENTEROLOGY
- Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways
- (2014) Ludovic Ménard et al. Nature Communications
- A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma
- (2013) M Yashiro et al. BRITISH JOURNAL OF CANCER
- Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
- (2013) M. Moschetta et al. CLINICAL CANCER RESEARCH
- Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
- (2013) I. Canadas et al. CLINICAL CANCER RESEARCH
- A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2013) Lainie P. Martin et al. GYNECOLOGIC ONCOLOGY
- A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
- (2013) DOUGLAS C. MARCHION et al. ONCOLOGY REPORTS
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
- (2012) Jean-Philippe Cosse et al. Anti-Cancer Agents in Medicinal Chemistry
- Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K–Akt signaling
- (2012) Kelai Wang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
- (2012) Amir Avan et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia
- (2012) Charles V. Rajadurai et al. JOURNAL OF CELL SCIENCE
- Activating mutation in MET oncogene in familial colorectal cancer
- (2011) Deborah W Neklason et al. BMC CANCER
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78)
- (2011) Hui Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A direct role for Met endocytosis in tumorigenesis
- (2011) Carine Joffre et al. NATURE CELL BIOLOGY
- Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
- (2011) Geert J. L. H. van Leenders et al. PLoS One
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel
- (2010) Chu ONCOLOGY REPORTS
- Uniform Beads with Controllable Pore Sizes for Biomedical Applications
- (2010) Sung-Wook Choi et al. Small
- The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer
- (2008) Chung-Ta Lee et al. DISEASES OF THE COLON & RECTUM
- Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
- (2008) Stéphanie Kermorgant et al. JOURNAL OF CELL BIOLOGY
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- HGF Increases Cisplatin Resistance via Down-Regulation of AIF in Lung Cancer Cells
- (2007) Jin-Tang Chen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now